As a participant in the ATTAIN-1 clinical trial at CU Anschutz, Swaney is playing an essential role in determining the safety and efficacy of orforglipron, a first-of-its-kind oral GLP-1
10.3390/ma14154090 22 DiY.ZhangM.ChenY.SunR.ShenM.TianF.et al (2022)
These statements have not been evaluated by Health Canada or the FDA
Eisenberg T, Knauer H, Schauer A, Bttner S, Ruckenstuhl C, Carmona-Gutierrez D, Ring J, Schroeder S, Magnes C, Antonacci L, Fussi H, Deszcz L, Hartl R, Schraml E, Criollo A, Megalou E, Weiskopf D, Laun P, Heeren G, Breitenbach M, Grubeck-Loebenstein B, Herker E, Fahrenkrog B, Frhlich KU, Sinner F, Tavernarakis N, Minois N, Kroemer G, Madeo F (2009) Induction of autophagy by spermidine promotes longevity
doi: 10.1002/9780470123188.ch9 88 KramarenkoG